USANA Health Sciences, Inc. (NYSE:USNA) major shareholder Global Ltd Gull sold 40,000 shares of the company’s stock in a transaction on Thursday, September 6th. The shares were sold at an average price of $126.74, for a total value of $5,069,600.00. Following the completion of the sale, the insider now owns 10,048,831 shares in the company, valued at $1,273,588,840.94. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Global Ltd Gull also recently made the following trade(s):

  • On Tuesday, August 21st, Global Ltd Gull sold 60,000 shares of USANA Health Sciences stock. The shares were sold at an average price of $131.35, for a total value of $7,881,000.00.
  • On Thursday, August 9th, Global Ltd Gull sold 90,000 shares of USANA Health Sciences stock. The shares were sold at an average price of $131.03, for a total value of $11,792,700.00.
  • On Monday, August 6th, Global Ltd Gull sold 100,000 shares of USANA Health Sciences stock. The stock was sold at an average price of $131.00, for a total value of $13,100,000.00.
  • On Tuesday, July 31st, Global Ltd Gull sold 100,000 shares of USANA Health Sciences stock. The stock was sold at an average price of $131.50, for a total value of $13,150,000.00.
  • On Thursday, August 2nd, Global Ltd Gull sold 140,000 shares of USANA Health Sciences stock. The stock was sold at an average price of $130.69, for a total value of $18,296,600.00.
  • On Monday, July 2nd, Global Ltd Gull sold 30,796 shares of USANA Health Sciences stock. The stock was sold at an average price of $115.18, for a total value of $3,547,083.28.
  • On Tuesday, December 4th, Global Ltd Gull sold 6,681 shares of USANA Health Sciences stock. The stock was sold at an average price of $70.47, for a total value of $470,810.07.
  • On Saturday, December 1st, Global Ltd Gull sold 12,436 shares of USANA Health Sciences stock. The stock was sold at an average price of $70.45, for a total value of $876,116.20.
  • On Tuesday, December 11th, Global Ltd Gull bought 10,396 shares of USANA Health Sciences stock. The shares were acquired at an average price of $70.70 per share, for a total transaction of $734,997.20.
  • On Saturday, December 8th, Global Ltd Gull bought 824 shares of USANA Health Sciences stock. The shares were acquired at an average price of $70.70 per share, for a total transaction of $58,256.80.

NYSE USNA traded up $0.40 during trading hours on Friday, hitting $125.15. 4,023 shares of the company’s stock were exchanged, compared to its average volume of 128,237. USANA Health Sciences, Inc. has a 12-month low of $55.50 and a 12-month high of $137.95. The company has a market capitalization of $3.05 billion, a PE ratio of 30.74 and a beta of 0.64.

USANA Health Sciences (NYSE:USNA) last released its earnings results on Tuesday, July 24th. The company reported $1.36 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.11 by $0.25. USANA Health Sciences had a return on equity of 29.50% and a net margin of 7.16%. The firm had revenue of $301.50 million for the quarter, compared to the consensus estimate of $278.41 million. During the same period in the prior year, the business posted $0.98 earnings per share. The firm’s revenue for the quarter was up 17.3% compared to the same quarter last year. sell-side analysts predict that USANA Health Sciences, Inc. will post 4.9 EPS for the current fiscal year.

Separately, Pivotal Research reiterated a “hold” rating and set a $135.00 target price on shares of USANA Health Sciences in a research report on Wednesday, July 25th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company. USANA Health Sciences currently has a consensus rating of “Hold” and a consensus target price of $135.00.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Robecosam AG acquired a new stake in USANA Health Sciences during the first quarter worth about $126,000. SG Americas Securities LLC acquired a new stake in USANA Health Sciences during the first quarter worth about $137,000. O Shaughnessy Asset Management LLC acquired a new stake in USANA Health Sciences during the first quarter worth about $179,000. Burney Co. acquired a new stake in USANA Health Sciences during the first quarter worth about $206,000. Finally, Susquehanna Fundamental Investments LLC acquired a new stake in USANA Health Sciences during the first quarter worth about $206,000. Hedge funds and other institutional investors own 56.38% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.

See Also: How Do You Make Money With Penny Stocks?

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.